Raybow Tablet 50 mg (Lasmiditan Hemisucsinate)

Adult dose

This medicine should not be taken to prevent migraine. ○ Adults The recommended dose is 50mg, 100mg, or 200mg orally as a single dose, as needed. Do not take more than one dose within 24 hours, and do not drive or operate machinery within 8 hours after taking this medicine. A second dose of this medicine for the same migraine attack has been shown to be ineffective. The safety of treatment for more than an average of 4 migraine attacks per 30 days has not been established. This medicine may be taken with or without food. Patients with renal impairment No dose adjustment is needed based on renal function. Patients with hepatic impairment No dose adjustment is needed in patients with mild or moderate hepatic impairment (Child-Pugh A or B). This medicine has not been studied in patients with severe hepatic impairment (Child-Pugh C), and use in these patients is not recommended.

This medication should not be used in certain patients. For instance, patients who are allergic to this medication or its additives or who have severe liver disease should avoid taking it. Care should be taken when administering this medication to patients with uncontrolled hypertension, those taking alcohol or other central nervous system depressants, pregnant women or those who may become pregnant, nursing mothers, and the elderly. While taking this medication, caution is required as side effects such as dizziness, fatigue, sensory disturbances, and drowsiness may occur. Particularly, dizziness and drowsiness are common after taking this medication. After taking this medication, activities that require concentration, such as driving or operating machinery, should be avoided for at least 8 hours. This is because the medication may impair mental clarity or cause drowsiness. Additionally, this medication may lower heart rate and temporarily increase blood pressure, so caution is necessary for patients with heart disease or those taking other medications that lower heart rate. Combining this medication with other serotonergic drugs may lead to a dangerous condition known as serotonin syndrome; therefore, patients taking serotonergic medications should consult their doctor before use. The safety of this medication during pregnancy or breastfeeding is not established, so it is essential to consult a healthcare professional before taking it. This medication is not recommended for use in children or patients under 18 years of age, as safety and efficacy have not been established. Elderly patients may experience more severe dizziness or increased blood pressure when taking this medication, so starting at a lower dose and careful monitoring is advised. This medication should be kept out of reach of children and stored at room temperature below 30 degrees Celsius, in its original container.

• Dizziness
• fatigue
• sensory disturbance
• sedation
• nausea and/or vomiting
• muscle weakness
• vertigo
• coordination disorder
• somnolence
• visual impairment

This medication may be sensitive to air and moisture; therefore, it must be stored in a tightly sealed container. It is safe to store this medication at room temperature between 1 and 30 degrees Celsius, away from excessively hot or cold conditions.

Appearance

Light gray oval film-coated tablet

Package unit

2 tablets/box [2 tablets/PTP X 1], 6 tablets/box [2 tablets/PTP X 3], 12 tablets/box [2 tablets/PTP X 6], 16 tablets/box [2 tablets/PTP X 8]